ANTONE OPEKUN to Administration, Oral
This is a "connection" page, showing publications ANTONE OPEKUN has written about Administration, Oral.
Connection Strength
0.092
-
Novel therapies for Helicobacter pylori infection. Aliment Pharmacol Ther. 1999 Jan; 13(1):35-42.
Score: 0.033
-
Improved Starch Digestion of Sucrase-deficient Shrews Treated With Oral Glucoamylase Enzyme Supplements. J Pediatr Gastroenterol Nutr. 2017 08; 65(2):e35-e42.
Score: 0.030
-
Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology. 1999 Jul; 117(1):40-8.
Score: 0.009
-
Recombinant Norwalk virus-like particles as an oral vaccine. Arch Virol Suppl. 1996; 12:243-9.
Score: 0.007
-
Leucine oxidation changes rapidly after dietary protein intake is altered in adult women but lysine flux is unchanged as is lysine incorporation into VLDL-apolipoprotein B-100. J Nutr. 1994 Jan; 124(1):41-51.
Score: 0.006
-
Non-replicating oral whole cell vaccine protective against enterotoxigenic Escherichia coli (ETEC) diarrhea: stimulation of anti-CFA (CFA/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to heterologous serotypes. FEMS Microbiol Immunol. 1988 Dec; 1(3):117-25.
Score: 0.004
-
Immunoprotective oral whole cell vaccine for enterotoxigenic Escherichia coli diarrhea prepared by in situ destruction of chromosomal and plasmid DNA with colicin E2. FEMS Microbiol Immunol. 1988 Jan; 1(1):9-18.
Score: 0.004